Lupin has posted steady U.S. growth and a continually expanding pipeline of new products and initiatives since establishing its U.S. base of operations.

Cool Timeline

Lupin founded
lupin pharmaceuticals founded in baltimore, maryland in 2003

Lupin Pharmaceuticals Inc. founded in Baltimore, Maryland for marketing and developmental activities in the U.S.

Generics business launched
lupin pharmaceuticals launched generics business in 2005

Generics business launched in the U.S. with 5 products

5th largest generic manufacturer in the U.S. by prescriptions dispensed
lupin pharmaceuticals emerges as the 5th largest generic manfacturer in the united states in 2010

Emerges as the 5th largest manufacturer player in the U.S.

Center of Excellence facility
lupin pharmaceuticals announces center of excellence facility for inhalation research in 2015

Lupin announces new Center of Excellence facility for Inhalation Research in Coral Springs, Florida

lupin pharmaceuticals acquires novel laboratories and creates lupin somerset in 2016

By acquiring Novel Laboratories, Inc. Lupin created Lupin Somerset, Lupin’s first U.S.- based commercial manufacturing facility

U.S. Revenue exceeds $1 Billion
lupin pharmaceuticals united states revenue exceeds $1 billion in 2017

Fiscal year 2017 marked a milestone for Lupin as our U.S. revenues surpassed the USD 1 billion mark; a growth of 37% over fiscal year 2016 (revenues FY2017 were $1,207 million vs. $883 million in FY2016)

Solosec® (secnidazole) launched
lupin pharmaceuticals launches solosec in the united states in 2018

Solosec® (secnidazole) launched in the U.S.